Rasburicase Utilization After Protocol Implementation Focused on Fixed Dosing by Limiting Use of Weight-Based Dosing to Oncology Providers

Authors

Dakota Smith BS
Jamie Gaul PharmD, BCPS, Parkview HealthFollow
Liam Dadey PharmD, BCPS, Parkview HealthFollow

Abstract

Dec 2021 ASHP Midyear Clinical Meeting / Poster

Objective: Evaluate the change in rasburicase use pre- and post-implementation of dosing restriction protocol.

Document Type

Article

Publication Date

2021

Recommended Citation

Smith, Dakota BS; Gaul, Jamie PharmD, BCPS; and Dadey, Liam PharmD, BCPS, "Rasburicase Utilization After Protocol Implementation Focused on Fixed Dosing by Limiting Use of Weight-Based Dosing to Oncology Providers" (2021). Parkview Pharmacy Department. 58.
https://researchrepository.parkviewhealth.org/pharma/58